Anti-Transglutaminase 2 Antibody (A94732)

Name: Anti-Transglutaminase 2 Antibody
Brand: Antibodies.com
SKU: A94732
Price: 115.0 GBP
Availability: InStock

Enlarge Image

This product is discontinued

Anti-Transglutaminase 2 Antibody (A94732) has been discontinued and is no longer available.

View all TGM2 Antibodies.

Specifications

Name

Anti-Transglutaminase 2 Antibody

Description

Rabbit polyclonal antibody to Transglutaminase 2.

Applications

WB, IHC, ELISA

Dilutions

WB: 1:500~1:1000, IHC: 1:50~1:100, ELISA: 1:5000

Reactivity

Human, Mouse

Immunogen

Synthetic peptide derived from human Transglutaminase 2 (amino acids 1-50).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing peptide.

Molecular Weight

77kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

Erythrocyte transglutaminase, G(h, Heart G alpha(h, hhG alpha(h, Isopeptidase TGM2, Protein G alpha(h, Protein-glutamine deamidase TGM2, Protein-glutamine gamma-glutamyltransferase 2

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (2)

Enlarge Image

Western Blot - Anti-Transglutaminase 2 Antibody (A94732)

Western blot analysis of lysates from HUVEC cells using Anti-Transglutaminase 2 Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.

Enlarge Image

Immunohistochemistry - Anti-Transglutaminase 2 Antibody (A94732)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using Anti-Transglutaminase 2 Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.